Sign in
4

Changes in Ownership

PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001140361-14-013997

Chief Technology Officer acquired 639,248 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

WACHTER ERIC PHD · Chief Technology Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2014-03-20 Exercise or conversion : show line 1 in the form +25,000 $0.95 $23,750 5,418,236 D
2014-03-20 Exercise or conversion : show line 2 in the form +14,248 $0.75 $10,686 5,432,484 D
2014-03-20 Exercise or conversion : show line 3 in the form +600,000 $0.93 $558,000 6,032,484 D

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2014-03-20 Exercise or conversion : show line 4 in the form Employee Stock Option (Right to buy) −25,000 0 D
2014-03-20 Exercise or conversion : show line 5 in the form Employee Stock Option (Right to buy) −14,248 0 D
2014-03-20 Exercise or conversion : show line 6 in the form Employee Stock Option (Right to buy) −600,000 0 D
Loading xslF345X03/doc1.xml…